Related Experiment Video
Updated: Aug 9, 2026
06:05
Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
Published on: September 30, 2014
Beta-lactamases and beta-lactamase inhibitors
1University of London, UK.
International Journal of Antimicrobial Agents
|October 20, 1999
Summary
Beta-lactam antibiotics are crucial for treating bacterial infections. Beta-lactamase inhibitors restore their effectiveness against resistant bacteria, ensuring continued clinical use.
Area of Science:
- Microbiology
- Pharmacology
- Medicinal Chemistry
Background:
- Beta-lactam antibiotics, including penicillins, have been vital since the 1940s.
- Bacterial resistance to beta-lactams emerged early, primarily through beta-lactamase enzymes.
- These enzymes degrade the core beta-lactam ring, compromising antibiotic efficacy.
Purpose of the Study:
- To review the significance of beta-lactamase-mediated resistance.
- To highlight the role of beta-lactamase inhibitors in overcoming resistance.
- To emphasize the continued clinical utility of beta-lactam antibiotics.
Main Methods:
- Literature review of beta-lactam antibiotic history and resistance mechanisms.
- Analysis of beta-lactamase enzyme function and plasmid-mediated spread.
- Evaluation of the efficacy of beta-lactam/beta-lactamase inhibitor combinations.
Main Results:
- Beta-lactamase-mediated hydrolysis is the most prevalent resistance mechanism.
- Plasmids facilitate the widespread dissemination of beta-lactamase genes.
- Beta-lactamase inhibitors effectively neutralize these enzymes, restoring antibiotic activity.
Conclusions:
- Beta-lactamase inhibitors are essential for maintaining the clinical effectiveness of beta-lactam antibiotics.
- Combinations of beta-lactams and inhibitors allow for continued treatment of bacterial infections.
- These combinations ensure the reliable use of well-tolerated and effective antibiotics.
Related Concept Videos
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...